Publication:
Comparison of infants and children with urolithiasis: A large case series

dc.contributor.authorGÖKCE, İBRAHİM
dc.contributor.authorsBastug F., Agbas A., Tulpar S., Yildirim Z. N. Y., Cicek N., Gunay N., Gemici A., Celik B., Delebe E. O. C., Nalcacioglu H., et al.
dc.date.accessioned2023-05-24T06:19:49Z
dc.date.accessioned2026-01-10T16:51:03Z
dc.date.available2023-05-24T06:19:49Z
dc.date.issued2022-08-01
dc.description.abstractWe evaluated the demographic features, etiologic risk factors, treatment strategies, and outcome of the infants and children with urolithiasis (UL). A retrospective multicenter study was conducted including 23 Pediatric Nephrology centers in Turkey. The medical records of 2513 children with UL were reviewed. One thousand, three hundred and four boys and 1209 girls (1.1:1) were reported. The mean age at diagnosis was 39.5 +/- 35 months (0.4-231 months), and 1262 patients (50.2%) were in the first year of life (infants). Most of the cases with infantile UL were diagnosed incidentally. Microlithiasis (< 3 mm) was found in 794 patients (31.6%), and 64.5% of the patients with microlithiasis were infants. Stones were located in the pelvis-calyces in 63.2% (n: 1530) of the cases. The most common stone type was calcium oxalate (64.6%). Hypocitraturia was the most common metabolic risk factor (MRF) in children older than 12 months, but in infancy, hypercalciuria was more common. Fifty-five percent of the patients had received at least one medical treatment, mostly potassium citrate. At the end of a year\"s follow-up, most of the patients with microlithiasis (85%) showed spontaneous remission. The rate of spontaneous stone resolution in infants was higher than in children. Spontaneous remission rate was higher in cases with MRF ( - ) stones than in MRF ( +) stones. However, remission rate with medical treatment was higher in cases with MRF ( +) stones. This study represents the results of a large series of infants and children with UL and showed that there are several differences such as underlying metabolic and anatomic abnormalities, clinical course, and stone remission rates between infants and children with urinary stone disease.
dc.identifier.citationBastug F., Agbas A., Tulpar S., Yildirim Z. N. Y., Cicek N., Gunay N., Gemici A., Celik B., Delebe E. O. C., Nalcacioglu H., et al., "Comparison of infants and children with urolithiasis: a large case series", UROLITHIASIS, cilt.50, sa.4, ss.411-421, 2022
dc.identifier.doi10.1007/s00240-022-01327-0
dc.identifier.endpage421
dc.identifier.issn2194-7228
dc.identifier.issue4
dc.identifier.startpage411
dc.identifier.urihttps://pubmed.ncbi.nlm.nih.gov/35482085/
dc.identifier.urihttps://hdl.handle.net/11424/289564
dc.identifier.volume50
dc.language.isoeng
dc.relation.ispartofUROLITHIASIS
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectNefroloji
dc.subjectMedicine
dc.subjectHealth Sciences
dc.subjectInternal Medicine Sciences
dc.subjectInternal Diseases
dc.subjectNephrology
dc.subjectÜROLOJİ VE NEFROLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectUROLOGY & NEPHROLOGY
dc.subjectCLINICAL MEDICINE
dc.subjectClinical Medicine (MED)
dc.subjectÜroloji
dc.subjectUrology
dc.subjectUrolithiasis
dc.subjectInfants
dc.subjectChildren
dc.subjectRisk factors
dc.subjectOutcome
dc.subjectMETABOLIC RISK-FACTORS
dc.subjectURINARY STONE DISEASE
dc.subjectPEDIATRIC UROLITHIASIS
dc.subjectVITAMIN-D
dc.subject1ST YEAR
dc.subjectEPIDEMIOLOGY
dc.subjectEXPERIENCE
dc.subjectDIAGNOSIS
dc.subjectAGE
dc.subjectUrolithiasis
dc.subjectInfants
dc.subjectChildren
dc.subjectRisk factors
dc.subjectOutcome
dc.titleComparison of infants and children with urolithiasis: A large case series
dc.typearticle
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
file.pdf
Size:
498.76 KB
Format:
Adobe Portable Document Format